IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function.

Area of Science:

• Immunology
• Respiratory Medicine
• Cell Biology

Background:

• Chronic respiratory diseases like asthma involve mucus overproduction and impaired mucociliary function, primarily linked to IL-13 effects on secretory and ciliated cells.
• The function of rare airway cells, such as tuft cells, in type 2 (T2) inflammation remains largely unexplored, despite their known role in intestinal immunity.

Purpose of the Study:

• To investigate the role of airway tuft cells in type 2 (T2) inflammatory responses.
• To determine how IL-13 signaling affects airway tuft cell function and metabolism.
• To elucidate the mechanisms by which tuft cells influence mucociliary function in allergic airways.

Main Methods:

• Bulk and single-cell RNA sequencing of airway epithelium.
• Development and utilization of mouse models for airway inflammation.
• Measurement of prostaglandin E2 (PGE2) levels in the airway.
• Assessment of ion and fluid secretion and mucociliary transport.

Main Results:

• IL-13 was found to expand airway tuft cells and promote their eicosanoid metabolism.
• Tuft cell deficiency resulted in decreased airway prostaglandin E2 (PGE2) concentrations.
• Allergic airway epithelia exhibited a signature of PGE2 activation.
• PGE2 activation stimulated cystic fibrosis transmembrane receptor-dependent ion and fluid secretion, accelerating mucociliary transport.

Conclusions:

• Airway tuft cells play a significant role in regulating epithelial mucociliary function during allergic airway inflammation.
• IL-13-mediated programming of tuft cells towards eicosanoid metabolism is a key pathway in T2 airway inflammation.
• Tuft cell-derived PGE2 is a critical mediator of ion and fluid secretion and mucociliary clearance in allergic airways.